CHIARANTINI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 11.280
EU - Europa 7.754
AS - Asia 4.566
SA - Sud America 434
AF - Africa 56
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 12
Totale 24.126
Nazione #
US - Stati Uniti d'America 11.168
GB - Regno Unito 2.675
CN - Cina 2.252
SG - Singapore 1.317
IT - Italia 1.292
UA - Ucraina 1.060
SE - Svezia 623
RU - Federazione Russa 557
FI - Finlandia 464
DE - Germania 428
TR - Turchia 392
BR - Brasile 321
VN - Vietnam 224
FR - Francia 221
IE - Irlanda 214
IN - India 90
CA - Canada 74
AR - Argentina 45
KR - Corea 44
HK - Hong Kong 39
PL - Polonia 39
ES - Italia 36
BD - Bangladesh 34
BE - Belgio 33
NL - Olanda 31
JP - Giappone 27
MX - Messico 23
EC - Ecuador 22
AU - Australia 19
IQ - Iraq 15
IR - Iran 14
SA - Arabia Saudita 14
ZA - Sudafrica 12
AE - Emirati Arabi Uniti 11
AT - Austria 11
CO - Colombia 11
MA - Marocco 11
PK - Pakistan 11
CL - Cile 10
EU - Europa 10
PY - Paraguay 10
ID - Indonesia 9
UZ - Uzbekistan 9
TG - Togo 8
AZ - Azerbaigian 7
CH - Svizzera 7
EE - Estonia 7
KE - Kenya 7
JO - Giordania 6
KZ - Kazakistan 6
LT - Lituania 6
VE - Venezuela 6
CZ - Repubblica Ceca 5
IL - Israele 5
NZ - Nuova Zelanda 5
PA - Panama 5
BG - Bulgaria 4
BO - Bolivia 4
DK - Danimarca 4
EG - Egitto 4
HN - Honduras 4
LA - Repubblica Popolare Democratica del Laos 4
MY - Malesia 4
PE - Perù 4
SK - Slovacchia (Repubblica Slovacca) 4
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
HU - Ungheria 3
KG - Kirghizistan 3
LU - Lussemburgo 3
LV - Lettonia 3
NP - Nepal 3
OM - Oman 3
PT - Portogallo 3
RO - Romania 3
RS - Serbia 3
TH - Thailandia 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AM - Armenia 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CR - Costa Rica 2
CY - Cipro 2
GE - Georgia 2
GR - Grecia 2
KH - Cambogia 2
LK - Sri Lanka 2
MD - Moldavia 2
PH - Filippine 2
PS - Palestinian Territory 2
SN - Senegal 2
AO - Angola 1
BH - Bahrain 1
ET - Etiopia 1
HR - Croazia 1
IM - Isola di Man 1
IS - Islanda 1
Totale 24.116
Città #
Southend 2.440
Fairfield 1.049
Woodbridge 1.046
Ashburn 977
Jacksonville 861
Houston 859
Chandler 689
Ann Arbor 659
Singapore 653
San Jose 645
Cambridge 473
Nanjing 460
Seattle 444
Wilmington 397
Dallas 358
Izmir 309
Beijing 261
Urbino 238
Boardman 216
Dublin 214
Helsinki 200
Nanchang 168
New York 168
Los Angeles 139
San Mateo 129
Council Bluffs 126
Princeton 125
Lauterbourg 116
Moscow 102
Shenyang 99
Jiaxing 86
Hebei 82
Tianjin 81
Düsseldorf 79
Munich 72
Changsha 68
Ho Chi Minh City 68
Mülheim 56
Jinan 55
Shanghai 53
Milan 52
Kunming 51
San Diego 50
Istanbul 45
San Francisco 44
Hanoi 43
Bremen 42
Frankfurt am Main 42
Ancona 40
São Paulo 40
Buffalo 39
Guangzhou 37
Santa Clara 37
Orem 36
Hong Kong 34
Rome 33
London 32
Seongnam 30
Toronto 30
Brussels 29
Hangzhou 28
Warsaw 28
Velikiy Novgorod 27
Denver 26
Ningbo 24
Turku 24
The Dalles 23
Tokyo 23
Chennai 22
Zhengzhou 22
Des Moines 20
Stockholm 20
Poplar 18
Taizhou 18
Atlanta 17
Brooklyn 17
Chicago 17
Amsterdam 16
Boston 16
Bologna 15
Montreal 15
Dong Ket 14
Lanzhou 13
Phoenix 13
Mumbai 12
Rio de Janeiro 12
Auburn Hills 10
Fuzhou 10
Johannesburg 10
Melbourne 10
Perugia 10
Shenzhen 10
Turin 10
Bellaria-Igea Marina 9
Haikou 9
Mergo 9
Norwalk 9
Nuremberg 9
Osimo 9
Querétaro 9
Totale 16.739
Nome #
Targeting SARS-CoV-2 by synthetic dual-acting thiol compounds that inhibit Spike/ACE2 interaction and viral protein production 547
Glutathione Depletion Is Linked with Th2 Polarization in Mice with a Retrovirus-Induced Immunodeficiency Syndrome, Murine AIDS: Role of Proglutathione Molecules as Immunotherapeutics 433
In vitro effects on calcium oxalate crystallization kinetics and crystal morphology of an aqueous extract from Ceterach officinarum: analysis of a potential antilithiatic mechanism 330
Bacteria-produced ferric exopolysaccharide nanoparticles as iron delivery system for truffles (Tuber borchii) 314
Chitosan Nanoparticles for Topical Co-Administration of the Antioxidants Glutathione and Idebenone: Characterization and In Vitro Release 302
Design, synthesis and biological activity of hydrogen peroxide responsive arylboronate melatonin hybrids 296
Inhibition of murine AIDS by pro-glutathione (GSH) molecules 277
2',3'-Dideoxycytidine induced drug resistance in human cells 276
2',3'-Dideoxycytidine metabolism in a new drug-resistant cell line 270
Pharmacokinetic and antiretroviral activity in mice of oral [P(1),P(2)-bis[2-(adenin-9-yl)ethoxymethyl]phosphonate], a prodrug of 9-(2-phosphonylmethoxyethyl)adenine 265
A versatile vector system for generating recombinant EGFP-tagged proteins in yeast 263
Characterization and complementation of a Fus3/Kss1 type MAPK from Tuber borchii, TBMK 256
Comparison of novel delivery systems for antisense peptide nucleic acids 252
2',3'-Dideoxycytidine induced drug-resistance in human cells 252
Drug delivery through phagocytosis of red blood cells 251
Erythrocyte-based drug delivery 251
Enhanced antisense effect of modified PNAs delivered through functional PMMA microspheres 237
Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model. 233
Inhibition of macrophage iNOS by selective targeting of antisense PNA. 231
Inhibition of murine AIDS by combination of AZT and dideoxycytidine 5'-triphosphate 230
A Dinuclear Copper(II) Complex as Nitric Oxide Trapper in a Stimulated Murine Macrophage Model 227
Antiretroviral effect of combined zidovudine and reduced glutathione therapy in murine AIDS. 227
Development of a multilevel approach for the evaluation of nanomaterials toxicity 221
ATP modifications in hexokinase deficient fibroblasts exposed to nutrient shifts. 219
Novel biocompatible anionic polymeric microspheres for the delivery of the HIV-1 Tat protein for vaccine application 219
Glucose metabolism in fibroblasts from patients with erythrocyte hexokinase deficiency. 217
Repeated cycles of alternate administration of fludarabine and zidovudine plus didanosine inhibits murine AIDS and reduces proviral DNA content in lymph nodes to undetectable levels 215
Novel biocompatible anionic polymeric microspheres for the delivery of the HIV-1 Tat protein for vaccine application 215
Inhibition of murine AIDS by reduced glutathione. 213
Cloning and expression of a new human polypeptide which regulates protein phosphorylation in Escherichia coli 212
New treatment protocol including lympholytic and antiretroviral drugs to inhibit murine AIDS 211
Red blood cells as glucocorticoids delivery system. 207
Heat stress-activated, calcium dependent nitric oxide synthase in sponges 205
The use of Eudragit RS 100/cyclodextrin nanoparticles for the transmucosal administration of glutathione. 203
Simultaneous extraction and HPLC determination of ATP, ADP, AMP, NADP+ NADPH, NAD+ and NADH in human red blood cells. 202
Core-shell nanospheres for oligonucleotide delivery. V: adsorption/release behavior of 'stealth' nanospheres 201
Glucose 1,6-diphosphate in the erythrocytes of various species of mammal 200
AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: homologous erythrocytes as a delivery system for preferential immunization with putative protective antigens 199
Dinuclear Copper (II) complex as nitric oxide scavenger in stimulated murine macrophage model 198
Bioreactivity and biocompatibility of a vitamin E-modified multi-layer hemodialysis filter 198
CYTOTOXICITY OF NANOPARTICLES 198
Simultaneous extraction and reverse-phase high-performance liquid chromatographic determination of adenine and pyridine nucleotides in human red blood cells 198
Red blood cell phagocytosis and lysis following oxidative damage by phenylhydrazine. 197
Purification, properties, and evidence for two subtypes of human placenta hexokinase type I. 197
CYTOTOXICITY AND PROINFLAMMATORY ACTIVITY OF DIESEL AND BIO-DIESEL EXHAUST PARTICLE ON HUMAN KERATINOCYTES. 197
TOXICITY COMPARISON OF DIESEL EXHAUST PARTICLE (DEP) FROM AN URBAN BUS ENGINE FUELLED WITH DIESEL OIL AND 'BIODIESEL' BLEND. 192
Human erythrocyte hexokinases are immunologically related 188
Red blood cell phagocytosis following hexokinase inactivation. 187
A New Dinuclear Copper(II) Complex to Trap Nitric Oxide 187
Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides 186
Inhibition of murine AIDS by combination of AZT and DDCTP-loaded erythrocytes 186
Immunological quantification of human hexokinase type I 185
Inhibition of Murine AIDS by a New Azidothymidine Homodinucleotide. 182
Red blood cells as a glucocorticoids delivery system 181
Human erythrocytes phosphoglucomutase: comparison of the kinetic properties of PGM1 and PGM2 isoenzymes 180
Esocinasi in fibroblasti umani. 180
Targeting dexamethasone to macrophages. 180
Modulated red blood cell survival by membrane protein clustering 180
Preparation and characterization of monoclonal antibodies to human hexokinase type I. 179
Inhibition of murine AIDS by a new azidothymidine homodinucleotide 179
High production of secondary metabolites and biological activities of Cydonia oblonga Mill. pulp fruit callus 177
In vivo survival and in vitro phagocytosis of engineered erythrocytes. 176
Red blood cell mediated delivery of recombinant HIV-1 Tat protein in mice induces anti-Tat protein in mice induces anti-Tat neutralizing antibodies and CTL. 174
Metabolism, mitochondrial uptake and toxicity of 2’,3’-dideoxycytidine 174
The interaction of phosphorylated sugars with human hexokinase I. 172
Inhibition of murine retrovirus induced immunodeficiency by nucleoside analogues and combination therapy. 172
Il glucoso 1,6 difosfato negli eritrociti di differenti specie di mammifero 171
Liposomes as carriers of the antiretroviral agent dideoxycytidine-5'-triphosphate. 171
Studi preliminari sull’effetto proinfiammatorio in cheratinociti umani della porzione idrosolubile del particolato atmosferico frazionato. 170
Disparities in Cancer Incidence in Armenia, 2013-2016: Setting Priorities for Preventive Interventions. 169
Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: immunogenicity and protection in mice 166
Erythrocytes as carriers of reduced glutathione (GSH) in the treatment of retroviral infections 166
Red blood cells as an antigen-delivery system. 164
Inhibition of murine AIDS by alternate administration of azidothimidine and fludarabine monofosfate. 164
Effetto dell'età sulla sopravvivenza degli eritrociti di topo. 163
Immunological studies on mammalian hexokinase 163
Role of hexokinase in the regulation of glucose metabolism in human erythrocytes. 162
Vaccination strategy using red blood cells as antigen delivery system. 162
In vitro and in vivo toxicity of 2',3'-dideoxycytidine in mice 160
Molecular basis of the 2',3'-dideoxycytidine induced drug-resistance in human cells 160
Red blood cells as carriers of drugs against retroviruses 158
Immunological studies on mammalian hexokinase. 157
Use of fluorescent probes for describing the process of encapsulation by hypotonic dialysis. 156
In vitro evaluation of nanomaterials toxicity 155
Bilancio di genere 2022 151
Similarities and differences between human and rat hexokinases type I. 151
Vie degradative del glucoso 1,6 difosfato negli eritrociti umani. 150
Role of macrophage protection in the development of murine AIDS. 150
Cine CUG (2022-2023) 149
Antinsense peptide nucleic acid delivered by core-shell microspheres. 149
Molecular basis of 2',3'-dideoxycytidine-induced drug resistance in human cells. 149
New drug combinations for the treatment of murine AIDS and macrophage protection. 148
Introduction to in vivo targeting. 146
Rabbit red blood cell hexokinase. Decay mechanism during reticulocyte maturation. 145
New delivery systems for antisense Peptide Nucleic Acids. 145
In vitro targeting of doxorubicin loaded canine erythrocytes to cytotoxic T-lymphocytes (CTLL). 143
NUCLEIC ACIDS AND PROTEIN DELIVERY THROUGH POLYMERIC CORE-SHELL NANOSPHERES 143
Inhibition of murine retrovirus induced immunodeficiency by nucleoside analogues and combination therapy. 142
Role of macrophage protection in the development of murine AIDS 142
Immobilization of enzymes and proteins on red blood cells. 140
Totale 20.039
Categoria #
all - tutte 83.037
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.037


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021113 0 0 0 0 0 0 0 0 0 0 0 113
2021/20221.277 80 120 157 191 40 46 56 73 82 65 23 344
2022/20232.475 235 104 40 225 194 456 7 152 537 137 277 111
2023/2024653 74 39 38 65 46 162 22 67 8 59 19 54
2024/20252.279 102 109 496 157 69 160 269 115 245 169 221 167
2025/20264.987 436 509 564 928 387 372 736 114 291 421 227 2
Totale 24.283